Canbridge gains China rights to APG101

Apogenix GmbH (Heidelberg, Germany) granted Canbridge Life Sciences Ltd. (Beijing, China) exclusive rights to APG101 in China, Macao and Hong Kong to treat glioblastoma

Read the full 245 word article

How to gain access

Continue reading with a
two-week free trial.